Literature DB >> 22718814

Hepatitis B virus nucleocapsid but not free core antigen controls viral clearance in mice.

Yi-Jiun Lin1, Hui-Lin Wu, Ding-Shinn Chen, Pei-Jer Chen.   

Abstract

We have recently shown that hepatitis B virus (HBV) core antigen (HBcAg) is the major viral factor for HBV clearance using a hydrodynamics-based mouse model. Knockout of HBcAg hampers the development of antiviral immune responses and thus promotes HBV persistence. Here, we further demonstrated that only in the capsid form, but not the free or dimer form, can HBcAg exert its contributory role in HBV clearance. HBcAg is the main structural protein of HBV icosahedral nucleocapsid. A mutant HBV DNA which expresses an assembly-defective HBcAg, HBcAgY132A, surprisingly prolonged HBV surface antigenemia in both C57BL/6 and BALB/c mice without affecting viral transcription and translation. This result was not due to a loss of the possible immune epitope caused by the single-amino-acid substitution of HBcAg. Moreover, the particular HBV mutant failed to induce robust humoral and cellular immunity against HBV. These data revealed the requirement of capsid structure for inducing adequate immunity that leads to HBV clearance in mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718814      PMCID: PMC3416136          DOI: 10.1128/JVI.00608-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

3.  Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity.

Authors:  J Zachary Porterfield; Mary Savari Dhason; Daniel D Loeb; Michael Nassal; Stephen J Stray; Adam Zlotnick
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

4.  Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.

Authors:  Shiyan Yu; Jieliang Chen; Min Wu; Hui Chen; Nobuyuki Kato; Zhenghong Yuan
Journal:  J Gen Virol       Date:  2010-04-07       Impact factor: 3.891

5.  Persistent effect of IFNAR-1 genetic polymorphism on the long-term pathogenesis of chronic HBV infection.

Authors:  Xing-Xing He; Ying Chang; Hua-Jun Jiang; Feng Tang; Fan-Ying Meng; Qiong-Hui Xie; Pei-Yuan Li; Yu-Hu Song; Ju-Sheng Lin
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

6.  Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection.

Authors:  Jie Zhou; Liwei Lu; Man-Fung Yuen; Ting-Wa Lam; Chi-Ping Chung; Chun-Lit Lam; Bin Zhang; Song Wang; Yu Chen; Sharon H W Wu; Vincent K M Poon; Fai Ng; Chris C S Chan; Shibo Jiang; Kwok-Yung Yuen; Bo-Jian Zheng
Journal:  J Hepatol       Date:  2006-10-17       Impact factor: 25.083

7.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection.

Authors:  J Zhou; D K Smith; L Lu; V K M Poon; F Ng; D-Q Chen; J-D Huang; K-Y Yuen; K-Y Cao; B-J Zheng
Journal:  J Viral Hepat       Date:  2008-08-28       Impact factor: 3.728

9.  Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus.

Authors:  Clifford S Guy; Patricia M Mulrooney-Cousins; Norma D Churchill; Tomasz I Michalak
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

10.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Authors:  P Fisicaro; C Valdatta; C Boni; M Massari; C Mori; A Zerbini; A Orlandini; L Sacchelli; G Missale; C Ferrari
Journal:  Gut       Date:  2009-02-06       Impact factor: 23.059

View more
  11 in total

Review 1.  Precore/core region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Seung Yeon Do; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

2.  Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission.

Authors:  Yongjun Tian; Cheng-Fu Kuo; Omid Akbari; Jing-Hsiung James Ou
Journal:  Immunity       Date:  2016-05-03       Impact factor: 31.745

3.  Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7.

Authors:  Baosen Jia; Minggao Guo; Gaiyun Li; Demin Yu; Xinxin Zhang; Ke Lan; Qiang Deng
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

4.  Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.

Authors:  Keigo Kawashima; Masanori Isogawa; Susumu Hamada-Tsutsumi; Ian Baudi; Satoru Saito; Atsushi Nakajima; Yasuhito Tanaka
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

5.  Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model.

Authors:  Horng-Tay Tzeng; Hwei-Fang Tsai; I-Tsu Chyuan; Hsiu-Jung Liao; Chun-Jen Chen; Pei-Jer Chen; Ping-Ning Hsu
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

6.  The IL-1R/TLR signaling pathway is essential for efficient CD8+ T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model.

Authors:  Zhiyong Ma; Jia Liu; Weimin Wu; Ejuan Zhang; Xiaoyong Zhang; Qian Li; Gennadiy Zelinskyy; Jan Buer; Ulf Dittmer; Carsten J Kirschning; Mengji Lu
Journal:  Cell Mol Immunol       Date:  2017-07-31       Impact factor: 11.530

7.  Endogenously Expressed Antigens Bind Mammalian RNA via Cationic Domains that Enhance Priming of Effector CD8 T Cells by DNA Vaccination.

Authors:  Jana Krieger; Petra Riedl; Katja Stifter; Gleyder Roman-Sosa; Thomas Seufferlein; Martin Wagner; Reinhold Schirmbeck
Journal:  Mol Ther       Date:  2019-01-22       Impact factor: 11.454

8.  HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice.

Authors:  Jau-Hau Horng; Wei-Hsiang Lin; Chang-Ru Wu; You-Yu Lin; Li-Ling Wu; Ding-Shinn Chen; Pei-Jer Chen
Journal:  J Biomed Sci       Date:  2020-05-28       Impact factor: 8.410

9.  Cationic domains in particle-forming and assembly-deficient HBV core antigens capture mammalian RNA that stimulates Th1-biased antibody responses by DNA vaccination.

Authors:  Jana Krieger; Katja Stifter; Petra Riedl; Reinhold Schirmbeck
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

10.  Hepatitis B Core Antigen Impairs the Polarization While Promoting the Production of Inflammatory Cytokines of M2 Macrophages via the TLR2 Pathway.

Authors:  Hongyu Yi; Ye Zhang; Xiaofei Yang; Mengyuan Li; Haifeng Hu; Jie Xiong; Ning Wang; Jingyi Jin; Yusi Zhang; Yun Song; Xian Wang; Lihua Chen; Jianqi Lian
Journal:  Front Immunol       Date:  2020-03-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.